![]() ![]() The growth and diversity of LNP-related publications and their distribution among research areas and applications, as well as countries and organizations, are examined. ![]() (1,2) The CAS Content Collection is the largest human-curated collection of published scientific knowledge, proven useful for quantitative analysis of global scientific publications against variables such as time, research area, formulation, application, and chemical composition. Furthermore, we present a landscape of LNP-related research based on a thorough analysis of the CAS Content Collection. We then discuss the multiple applications of LNPs, including drug delivery, medical imaging, cosmetics, and others. In this review, we provide an overview of the current knowledge regarding LNP structures and properties, primarily from the viewpoint of their pharmaceutical applications. This report is intended to serve as a useful resource for those interested in LNP nanotechnologies, their applications, and the global research effort for their development. Challenges and growth opportunities are also evaluated in other areas, such as medical imaging, cosmetics, nutrition, and agrochemicals. Recent advancements in LNP formulations as drug delivery platforms, such as antitumor and nucleic acid therapeutics and vaccine delivery systems, are discussed. Rising trends are identified, such as nanostructured lipid carriers and solid lipid nanoparticles becoming the preferred platforms for numerous formulations. ![]() Here, we present a landscape of LNP-related scientific publications, including patents and journal articles, based on analysis of the CAS Content Collection, the largest human-curated collection of published scientific knowledge. With their ability to encapsulate and deliver therapeutics to specific locations within the body and to release their contents at a desired time, LNPs provide a valuable platform for treatment of a variety of diseases. Subsequent generations of lipid nanocarriers, such as solid lipid nanoparticles, nanostructured lipid carriers, and cationic lipid–nucleic acid complexes, exhibit more complex architectures and enhanced physical stabilities. A number of liposomal drugs have been approved and applied to medical practice. Liposomes, an early version of LNPs, are a versatile nanomedicine delivery platform. Currently in the spotlight as vital components of the COVID-19 mRNA vaccines, LNPs play a key role in effectively protecting and transporting mRNA to cells. Lipid nanoparticles (LNPs) have emerged across the pharmaceutical industry as promising vehicles to deliver a variety of therapeutics. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |